Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SOLVO Biotechnology Resource Report Resource Website 1+ mentions |
SOLVO Biotechnology (RRID:SCR_003964) | SOLVO | commercial organization | Commercial organization that is a worldwide provider of drug transporter technology, assays and reagents. Leveraging their expertise in efflux and uptake transporters, they generate quality reports for submission to FDA / EMA. From small molecules to protein therapeutics, SOLVO can test all transporter needs. Drug transporter Services and Products include: * Over 100 solutions for a wide range of transporters * Uptake transporter assays * Efflux transporter assays in cellular and membrane-based models * Transporter Consultancy Services * FDA- and EMA-ready reports * Ready-to-use Kits * In vitro and in vivo methods for studying transporters in the BBB, intestine, liver and kidney * Custom assay development | assay, membrane transporter, diagnostic, drug discovery, transporter, membrane | is related to: MIP-DILI | nlx_158367 | SCR_003964 | SciCrunch Registry | Solvo Biotechnology ZRT | 2026-09-26 02:13:36 | 2 | ||||||||
|
Biomarkers of Anti-TNF Treatment Efficacy in Rheumatoid Arthritis - Unresponsive Populations Resource Report Resource Website |
Biomarkers of Anti-TNF Treatment Efficacy in Rheumatoid Arthritis - Unresponsive Populations (RRID:SCR_004019) | BATTER-UP | data or information resource, portal, topical portal | A consortium evaluating a new biomarker screening test that might help identify patients with rheumatoid arthritis (RA) who are unlikely to benefit from anti-tumor necrosis factor-alpha (TNFalpha) medications. BATTER-UP will enroll around 1,000 patients being treated by one of several marketed anti-TNF RA drugs: Enbrel, Remicade, Humira, Simponi, or Cimzia. Through data analyses and predictive response modeling, the consortium aims to better understand which patients with RA will derive the greatest benefit from TNF inhibitors. The investigators in this observational study will attempt to validate an 8-gene biomarker set based on work by Biogen Idec researchers as likely to predict anti-TNF responsiveness in patients with RA. In preliminary results, the 8-gene biomarker set predicted with 89% accuracy individuals who did not reach European League Against Rheumatism (EULAR) Disease Activity Score (DAS)-28 good response after 14 weeks of treatment. The 8 genes included in the screen are CLTB, MXRA7, CXorf52, COL4A3BP, YIPF6, FAM44A, SFRS2, and PGK1. Biological samples and clinical outcome information will be used to confirm and extend the utility of previously published biomarkers that can predict response to anti-TNF agents. These data may also generate new hypotheses for further testing. The BATTER-UP samples and data will be established as a reference set for investigation of personalized medicine in RA. The study will be a resource of DNA and other biological materials that can be investigated for biomarkers in the future as new technologies arise. | anti-tumor necrosis factor-alpha, gene, biomarker, drug development, basic research, personalized medicine, enbrel, remicade, humira, simponi, cimzia, cltb, mxra7, cxorf52, col4a3bp, yipf6, fam44a, sfrs2, pgk1, clinical, dna, serum, plasma, rna, whole blood |
uses: ClinicalTrials.gov is listed by: Consortia-pedia is related to: Feinstein Institute for Medical Research has parent organization: Feinstein Institute for Medical Research has parent organization: ClinicalTrials.gov |
Biogen Idec ; Bristol-Myers Squibb ; Centocor ; Crescendo Bioscience ; Genentech ; Medco Health Solutions ; Regeneron Pharmaceuticals ; Sanofi-Aventis |
nlx_158440 | SCR_004019 | SciCrunch Registry | Biomarkers of Anti-TNF-alpha Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients, Biomarkers of Anti-TNF- Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients (BATTER-UP), Biomarkers of Anti-TNF- Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients | 2026-09-26 02:13:37 | 0 | |||||||
|
SeqExpress Resource Report Resource Website |
SeqExpress (RRID:SCR_004013) | software resource | A cross-platform software that estimates gene/isoform expression level via mRNA-Seq data. SeqExpress exams the Sequencing bias in mRNA-Seq and correct it to get more accurate estimation. | c++, mrna-seq, qt |
is listed by: OMICtools has parent organization: SourceForge |
PMID:15746290 PMID:14988116 |
GNU General Public License v2 | OMICS_01289 | SCR_004013 | SciCrunch Registry | 2026-09-26 02:13:36 | 0 | ||||||||
|
NYU Data Catalog Resource Report Resource Website |
NYU Data Catalog (RRID:SCR_004012) | NYU Data Catalog | catalog, data or information resource, database | A searchable data catalog that facilitates researchers'' access to large datasets available either publicly or through institutional or individual licensing. Dataset records include information about the content of the dataset, how to access the dataset, and local experts within NYULMC and NYU to assist in the use of these datasets. The data catalog will expand to include internally generated datasets from NYULMC and NYU in the near future. Use the contact form if you are interested in submitting a dataset to the data catalog. | data set, health, population, health care | Cancer, Chronic disease | The community can contribute to this resource | nlx_158439 | SCR_004012 | SciCrunch Registry | NYU Health Sciences Library Data Catalog | 2026-09-26 02:13:36 | 0 | |||||||
|
W. Garfield Weston Foundation Resource Report Resource Website 1+ mentions |
W. Garfield Weston Foundation (RRID:SCR_004017) | Weston Foundation | institution | Foundation that gives grants in Canada for the benefit of Canadians and directs its resources to specific organizations in Education, Land Conservation and Science in Canada''s North. In addition, it provides funds to further Canada''s research in neuroscience. These programs are director-initiated and the Foundation therefore does not accept applications for funding. By law, the Foundation is only able to support Canadian charities that are registered with the Canadian Revenue Agency. These charities must have a CRA charitable number and offer programs benefiting Canadians in Canada. | education, land conservation, science, neuroscience, grant | is parent organization of: Weston Brain Institute | nlx_158436, grid.430570.5, Crossref funder ID: 501100000243 | https://ror.org/0512g3q82 | SCR_004017 | SciCrunch Registry | The W. Garfield Weston Foundation | 2026-09-26 02:13:36 | 1 | |||||||
|
CXR Biosciences Resource Report Resource Website |
CXR Biosciences (RRID:SCR_003961) | commercial organization | Commercial organization that provides preclinical services and expertise, specializing in investigative toxicology, exploratory and discovery toxicology, metabolism and pharmacokinetics. CXR Biosciences is now Concept Life Sciences. | preclinical, toxicology, metabolism, pharmacokinetics, in vitro, in vivo, analytic, genomics, microarray, toxicogenomics, compound, drug | is related to: MIP-DILI | nlx_158363 | https://www.linkedin.com/company/cxr-biosciences-ltd | SCR_003961 | SciCrunch Registry | Concept Life Sciences, CXR Biosciences Ltd. | 2026-09-26 02:13:35 | 0 | ||||||||
|
CCLG Resource Report Resource Website 10+ mentions |
CCLG (RRID:SCR_004137) | CCLG | data or information resource, disease-related portal, portal, topical portal | THIS RESORUCE IS NO LONGER IN SERVICE. Documented on April 27,2023. CCLG is an association of healthcare professionals involved in the treatment and care of children and younger teenagers with cancer, and underpins all the activity in pediatric oncology in the British Isles. CCLG is committed to research and development in the treatment of cancer in this age group, the ultimate goal of which is to maximize cure while minimizing the early and late side effects of treatment. Provision of information for patients and families is a core activity. The Children''s Cancer and Leukaemia Group was formed in 2006 as a result of the merger of the UK Children''s Cancer Study Group and the UK Childhood Leukaemia Working Party, both of which had been in existence since the 1970s. |
has parent organization: University of Leicester; Leicester; United Kingdom is parent organization of: CCLG Tissue Bank |
Cancer Research UK | THIS RESORUCE IS NO LONGER IN SERVICE | nlx_143573 | SCR_004137 | SciCrunch Registry | Childrens Cancer and Leukaemia Group, Children''s Cancer and Leukemia Group, Childrens Cancer and Leukemia Group, Children''s Cancer and Leukaemia Group | 2026-09-26 02:13:39 | 12 | |||||||
|
Biomarkers Across Neurodegenerative Diseases Resource Report Resource Website |
Biomarkers Across Neurodegenerative Diseases (RRID:SCR_004015) | BAND | consortium, data or information resource, funding resource, organization portal, portal | Consortium that launched a Request for Applications (RFA) to stimulate analyses across the Alzheimer's disease (AD) and Parkinson's disease (PD) research enterprises to engage in further data analysis of existing cohorts, including, but not limited to, biomarker discovery, standardization of assays, genetic profiles, and imaging modalities. The RFA aims to build on existing momentum to leverage similar activities and increase impact across the neurodegenerative disease spectrum. It also builds on recent evidence suggesting substantial overlap between AD, PD, and other neurodegenerative diseases pathologically, but also potentially biologically. The RFA is designed to enable preliminary pilot research or proof-of-principle studies utilizing data and/or samples from two large biomarker studies, the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the Parkinson's Progression Markers Initiative (PPMI), in order to garner further research support from other funding agencies. Application Deadline: March 19, 2014. Efforts under BAND include studies that: * analyze datasets to test hypotheses related to aging and neurodegenerative disorders; * seek to identify panels or pathways that may play a role in disease mechanisms, such as around inflammation; * pursue shared or disparate biochemical markers of disease risk, onset or progression; * assess potential commonalities across the disease spectrum, including around other neurological disorders such as Lewy body dementia. Recent data reported at the 2013 Alzheimer's Association's International Conference stimulated discussion in the research community about the possible cross talk between AD and PD. For example, underlying pathologies / biomarkers, such as cerebrospinal fluid (CSF) alpha-synuclein, have been measured in the sample sets collected for both diseases to help understand similarities and differences in these diseases. Furthermore, similar imaging modalities, such as MRI and PET, are being employed to interrogate changes that occur with disease progression. As therapeutic approaches are developed that may be disease-modifying for several neurodegenerative diseases, stratification of clinical trial populations based on biomarker profiles may increase the probability of success in demonstrating a beneficial effect. | biomarker, grant, standardization, assay, genetic profile, neuroimaging, request for application, data acquisition, method, quality control |
uses: ADNI - Alzheimer's Disease Neuroimaging Initiative uses: Parkinson's Progression Markers Initiative is listed by: Consortia-pedia is related to: Michael J. Fox Foundation for Parkinsons Research is related to: Weston Brain Institute has parent organization: Alzheimers Association has parent organization: Michael J. Fox Foundation for Parkinsons Research has parent organization: Weston Brain Institute |
alz.org ; Michael J. Fox Foundation for Parkinson's Research ; Weston Brain Institute |
nlx_158434 | SCR_004015 | SciCrunch Registry | 2026-09-26 02:13:36 | 0 | ||||||||
|
GABO:mi Resource Report Resource Website |
GABO:mi (RRID:SCR_003956) | GABO:mi | commercial organization | THIS RESOURCE IS OUT OF SERVICE, documented on July 23, 2021. Small and medium-sized enterprise (SME) that is expert in management of research projects. Initially, they provide support with help and advice when applying for European research grants - free of charge. From project start, they take over contract negotiations, financial management, reporting to the EC, meeting organization, public relations and much more. ARTTIC Innovation GmbH took over GAVBO:mi. | project management |
is related to: OncoTrack is related to: European Lead Factory is related to: EU-AIMS is related to: NEWMEDS is related to: ARTTIC Innovation GmbH |
grid.10404.31, ISNI: 0000 0004 0377 0748, nlx_158356 | https://ror.org/00a99v816 | SCR_003956 | SciCrunch Registry | GABO:mi Gesellschaft f??r Ablauforganisation :milliarium mbH & Co. KG, GABO MI Society for workflow management, GABO:mi Gesellschaft fur Ablauforganisation:milliarium mbH & Co. KG, GABO:mi Gesellschaft f??r Ablauforganisation:milliarium mbH & Co KG, GABO:mi Society for workflow management, GABO:mi Gesellschaft f??r Ablauforganisation:milliarium mbH & Co. KG, GABO:milliarium, GABO:mi Gesellschaft fur Ablauforganisation :milliarium mbH & Co. KG | 2026-09-26 02:13:35 | 0 | |||||||
|
Interface Europe Resource Report Resource Website |
Interface Europe (RRID:SCR_003955) | IE | commercial organization | THIS RESOURCE IS OUT OF SERVICE, documented on July 23, 2021.Commercial organization with expertise in European research and innovation that provide both science providers (researchers) and technology users (Industry including SMEs, public authorities, Universities, clusters, etc.) tailor-made services to give the highest possible European added value to their project. | European research and innovation |
is related to: MIP-DILI is parent organization of: MIP-DILI |
nlx_158364 | SCR_003955 | SciCrunch Registry | 2026-09-26 02:13:35 | 0 | |||||||||
|
Experimental Pharmacology and Oncology Berlin-Buch Resource Report Resource Website 1+ mentions |
Experimental Pharmacology and Oncology Berlin-Buch (RRID:SCR_003954) | EPO | commercial organization | A small and medium-sized enterprise (SME) that has expertise in preclinical pharmacology, pharmacokinetics, and toxicology for the characterization of novel anticancer therapeutics and predictive biomarkers like: cytostatics, biologicals (peptides, antibodies), (anti)-hormones, immunomodulators (cytokines), and gene therapeutics. EPO has modern laboratories licensed for animal experiments and gene technology (S2) and a broad panel of murine and human tumor models growing in immunocompetent (SPF-quality, syngeneic strains) or immunodeficient mice (nude, SCID, NOD/SCID). EPO has established imaging technologies to monitor in vivo tumor growth. | tumor model, pharmaceutical, oncology, in vitro, in vivo, antitumor, preclinical, pharmacology, pharmacokinetics, toxicology, anticancer, therapeutic, biomarker, imaging, testing, validation, target | is related to: OncoTrack | Tumor, Cancer | nlx_158355 | SCR_003954 | SciCrunch Registry | EPO - Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology Berlin-Buch, Experimental Pharmacology & Oncology Berlin-Buch GmbH, EPO Berlin-Buch GmbH, EPO-GmbH | 2026-09-26 02:13:38 | 2 | |||||||
|
Alacris Theranostics Resource Report Resource Website |
Alacris Theranostics (RRID:SCR_003953) | Alacris | commercial organization | Commercial organization that uses next generation sequencing technologies coupled with computational modeling of tumor and somatic tissues in order to identify individualized therapies for cancer patients. The company also uses these technologies to help pharmaceutical partners stratify patients for their clinical trials. Alacris has an exclusive worldwide commercial license for the computational modeling of tumors and somatic tissues using proprietary computational systems modeling technologies ModCell developed at the Max Planck Institute for Molecular Genetics (MPI-MG) in Berlin coupled with next generation sequencing and genotyping technology developed at Harvard Medical School in Boston. The company also is building up the first next generation sequencing center in Europe for clinical operations. | next generation sequencing, computational modeling, clinical trial, somatic tissue, genotyping, genomics, oncogenomics, diagnostics, therapy, disease model, drug, personalized medicine, biomarker, drug development, tumor model, analysis, oncology | is related to: OncoTrack | Tumor, Cancer | nlx_158354, grid.473915.d | https://ror.org/04a0gnr15 | SCR_003953 | SciCrunch Registry | Alacris Theranostics GmbH | 2026-09-26 02:13:35 | 0 | ||||||
|
ZENODO Resource Report Resource Website 5000+ mentions |
ZENODO (RRID:SCR_004129) | ZENODO | catalog, data or information resource, data repository, database, service resource, software repository, software resource, storage service resource | Repository for all research outputs from across all fields of science in any file format as well as both positive and negative results. They assign all publicly available uploads a Digital Object Identifier (DOI) to make the upload easily and uniquely citeable. They further support harvesting of all content via the OAI-PMH protocol. They promote peer-reviewed openly accessible research, and curate uploads. ZENODO allows users to create their own collection and accept or reject all uploads to it. They allow for uploading under a multitude of different licenses and access levels. | data set, software resource, video resource, audio track, image, poster, presentation, publication, digital preservation, digital archive, persistent identifier, digital object identifier, openaire orphan record repository |
is used by: NIH Heal Project is recommended by: NIDDK Information Network (dkNET) is recommended by: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases is listed by: re3data.org is listed by: DataCite is listed by: FAIRsharing is related to: OpenAIRE |
European Union FP7 OpenAIREplus 283595 | DOI:10.5281, nlx_158614, DOI:10.17616/R3QP53, DOI:10.25504/FAIRsharing.wy4egf, r3d100011858 | https://doi.org/10.17616/R3QP53, https://doi.org/10.17616/r3QP53, https://doi.org/10.5281/, https://dx.doi.org/10.5281/, https://fairsharing.org/10.25504/FAIRsharing.wy4egf, https://doi.org/10.17616/R35W56 | SCR_004129 | SciCrunch Registry | Zenodo | 2026-09-26 02:13:39 | 6074 | ||||||
|
Psynova Neurotech Resource Report Resource Website 1+ mentions |
Psynova Neurotech (RRID:SCR_003959) | Psynova | commercial organization | Commercial organization focused on the development and exploitation of novel biomarkers for psychiatric illnesses. They provide industrial and academic partners with comprehensive biomarker discovery services in commercial and collaborative projects. They operate in the field of psychiatric disorders and their products and services are designed to excel biomarker research. In 2010, Psynova Neurotech and its partner company Rules-Based-Medicine Inc (now MyriadRBM) conducted a beta launch of a blood test aiding in the diagnosis of schizophrenia (http://www.veripsych.com/). They are now refining the test and have shifted their focus to the development of new blood-based biomarker tests that aid in the diagnosis, prognosis and differential diagnosis of schizophrenia, bipolar disorder and major depression. They offer not only their pre-selceted Multiple Reaction Monitoring (MRM) and Multiplex Immunoassay products, but also custom build panels. If they are provided with a list of analyses to evaluate, they can produce an analytical panel according to individual needs utilizing either MRM or Multiplex Immunoassay technologies., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | biomarker, neuropsychiatry, preclinical, model, diagnosis, blood, drug response, immunoassay, brain tissue, mass spectrometry, analysis |
is related to: University of Cambridge; Cambridge; United Kingdom is related to: NEWMEDS |
Schizophrenia, Psychiatric disorder, Bipolar Disorder, Major Depressive Disorder | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158360 | SCR_003959 | SciCrunch Registry | Psynova Neurotech Ltd | 2026-09-26 02:13:35 | 9 | ||||||
|
Coordinating center for infectious diseases Resource Report Resource Website |
Coordinating center for infectious diseases (RRID:SCR_003958) | CCID, CH | government granting agency | http://www.thecommunityguide.org/uses/funding.html | has parent organization: Centers for Disease Control and Prevention | nlx_inv_1005039 | SCR_003958 | SciCrunch Registry | 2026-09-26 02:13:38 | 0 | ||||||||||
|
Relypsa Resource Report Resource Website |
Relypsa (RRID:SCR_004047) | RLYP | commercial organization | Biopharmaceutical company focused on development and commercialization of non-absorbed polymeric drugs to treat disorders in areas of renal, cardiovascular and metabolic diseases.February 2021 - Relypsa changed its name to Vifor Pharma. Company is focused on development and commercialization of late stage medicines that will change treatment paradigms and improve patients lives. | biopharmaceutical, pharmaceutical, drug, late stage medicines, late stage medicines commercialization, late stage medicines development | is related to: Kidney Health Initiative | nlx_158475 | SCR_004047 | SciCrunch Registry | Relypsa Inc., Vifor Pharma | 2026-09-26 02:13:40 | 0 | ||||||||
|
National Renal Administrators Association Resource Report Resource Website |
National Renal Administrators Association (RRID:SCR_003991) | NRAA | community building portal, data or information resource, portal | A nonprofit organization representing dialysis facilities and centers throughout the United States. It supports members from all types of providers including freestanding, hospital-based and national chains through the weekly e-mail newsletter, Renal Watch, the Annual Meeting, periodic workshops and other meetings. NRAA members include dialysis provider companies and management consulting companies and other companies involved in the End Stage Renal Disease (ESRD) industry and supportive of the purposes of NRAA. Individuals not directly employed or otherwise involved in companies that are NRAA members may join as individual Associate Members. The purposes for which the NRAA is organized are as follows: # To provide renal administrators the opportunity for gaining continuing education, obtaining peer recognition and expanding development in the profession. # To promote and encourage education and training for renal administrators. # To recognize individuals who have done or are doing noteworthy service in the field of renal administration. # To educate the public and members of governing bodies of health care organizations to understand the issues surrounding the practice of renal administration. # To represent the professional interests of renal administrators as a national representative spokesperson for the development and implementation of public policy. # To act as a resource on local and national ESRD issues. | kidney, dialysis | is related to: Kidney Health Initiative | Kidney disease, End Stage Renal Disease | nlx_158405 | SCR_003991 | SciCrunch Registry | 2026-09-26 02:13:36 | 0 | ||||||||
|
CADRO Resource Report Resource Website 1+ mentions |
CADRO (RRID:SCR_004046) | CADRO | controlled vocabulary, data or information resource | A classification system developed by the National Institute on Aging and the Alzheimer's Association that can be used to integrate and compare Alzheimer's disease (AD) research portfolios from public and private organizations supporting AD research in the US and abroad. The CADRO was constructed as a three-tier classification system organized around seven major categories: five in research and two resource-related: * Category A. Molecular Pathogenesis and Pathophysiology of Alzheimer's Disease * Category B. Diagnosis, Assessment and Disease Monitoring * Category C. Translational Research and Clinical Interventions * Category D. Epidemiology * Category E. Care, Support and Health Economics of Alzheimer's Diseases * Category F. Research Resources * Category G. Consortia and Public Private Partnerships * Category H. Alzheimer's Disease - Related Dementias Using information from project abstracts and research aims, the above categories were stratified into research topics and these were further divided into research themes. The three levels of classification are meant to enable a fine-grained portfolio analysis that can inform strategic planning and funding decisions. The CADRO was developed as a dynamic portfolio analysis tool that can be used to: (i) capture the changing landscape of AD research funded by different organizations, (ii) identify opportunities for coordination of support for AD research, and (iii) identify funding gaps as well as areas of overlap within and across organizations. | late adult human, alzheimer, aging |
is used by: IADRP has parent organization: Alzheimers Association has parent organization: National Institute on Aging |
Alzheimer's disease, Aging | NIA | nlx_158474 | http://www.nia.nih.gov/research/dn/cadro-outline, http://www.nia.nih.gov/research/dn/common-alzheimers-disease-research-ontology-cadro, http://www.nia.nih.gov/sites/default/files/cadro_outline_-_january_2013.pdf | SCR_004046 | SciCrunch Registry | Common Alzheimer''s Disease Research Ontology, Common Alzheimer's Disease Research Ontology (CADRO) | 2026-09-26 02:13:37 | 4 | |||||
|
NIMH Educational Resources Resource Report Resource Website |
NIMH Educational Resources (RRID:SCR_004045) | NIMH Educational Resources | data or information resource, narrative resource, portal, topical portal, training material | A portal to educational resources. | education, mental health, science, human, child, young human |
has parent organization: National Institute of Mental Health is parent organization of: Brain Basics is parent organization of: Neuroscience and Psychiatry Module 1: Translating Neural Circuits into Novel Therapeutics is parent organization of: Science of Mental Illness: Grades 6- 8 is parent organization of: Brain's Inner Workings: Activities for Grades 9 through 12 is parent organization of: Neuroscience and Psychiatry Module 2: Fear/Safety Anxiety and Anxiety Disorders |
NIMH | nlx_146225 | SCR_004045 | SciCrunch Registry | National Institute of Mental Health Educational Resources | 2026-09-26 02:13:37 | 0 | |||||||
|
Datahub Resource Report Resource Website 10+ mentions |
Datahub (RRID:SCR_003996) | data or information resource, data repository, database, service resource, storage service resource | Data management platform and data repository based on the CKAN tool for managing and publishing collections of data. It enables the user to search for data, register published datasets, create and manage groups of datasets, and get updates from datasets and groups of interest. | data set, data sharing, data management, ckan, data publishing |
uses: CKAN has parent organization: Alfred P. Sloan Foundation |
PMID:26844007 | Free, Freely available, | nlx_158409, r3d100000028 | https://old.datahub.io/ | SCR_003996 | SciCrunch Registry | 2026-09-26 02:13:36 | 14 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
